Verastem, Inc. Profile Avatar - Palmy Investing

Verastem, Inc.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated prot…

Biotechnology
US, Needham [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Verastem, Inc. has no acquisition track records yet.

M&A Deals · History

Verastem, Inc. has no acquisition track records yet.

End of VSTM's Analysis
CIK: 1526119 CUSIP: 92337C104 ISIN: US92337C2035 LEI: - UEI: -
Secondary Listings
VSTM has no secondary listings inside our databases.